molindone has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, S; Gopalakrishnan, G; Krishna, G | 1 |
| Cole, JO; Gardos, G | 1 |
| Herrera, J; Lawson, W; Parent, MM; Roy, S; Sramek, J | 1 |
| Abuzzahab, FS | 1 |
1 trial(s) available for molindone and Body Weight
| Article | Year |
|---|---|
Long-term use of molindone in schizophrenics.
Topics: Acute Disease; Adult; Antidepressive Agents; Body Weight; Clinical Trials as Topic; Female; Humans; Indoles; Male; Middle Aged; Molindone; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 1973 |
3 other study(ies) available for molindone and Body Weight
| Article | Year |
|---|---|
Toxicity assessment of molindone hydrochloride, a dopamine D2/D5 receptor antagonist in juvenile and adult rats.
Topics: Administration, Oral; Aging; Animals; Antipsychotic Agents; Body Weight; Dopamine D2 Receptor Antagonists; Female; Male; Molindone; Organ Size; Organ Specificity; Prolactin; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D3; Reproduction; Toxicokinetics | 2017 |
Weight reduction in schizophrenics by molindone.
Topics: Adult; Appetite Depressants; Behavior; Body Weight; Chronic Disease; Female; Hospitalization; Humans; Indoles; Male; Middle Aged; Molindone; Schizophrenia; Time Factors | 1977 |
Effect of molindone on weight change in hospitalized schizophrenic patients.
Topics: Adult; Aged; Body Weight; Hospitalization; Humans; Indoles; Male; Middle Aged; Molindone; Schizophrenia | 1986 |